Autori: Schadendorf Dirk
Naslov | Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study. (Meeting Abstract) |
Autori | Schadendorf Dirk ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P ... (broj koautora 20) |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2022), vol. 40 br. 16, Suppl. S, str. - |
Projekat | F. Hoffmann-La Roche Ltd. |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|